BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CTMSS - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CTMSS
X-ORIGINAL-URL:https://clinicaltmssociety.org
X-WR-CALDESC:Events for CTMSS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250506T200000
DTEND;TZID=America/New_York:20250506T210000
DTSTAMP:20260608T102921
CREATED:20250402T163454Z
LAST-MODIFIED:20260506T155456Z
UID:2262-1746561600-1746565200@clinicaltmssociety.org
SUMMARY:Grand Round Webinar: Research 101: What data can I report from my TMS practice\, and how can I report it?
DESCRIPTION:> >Register Now <<\nJoin the Clinical TMS Society for this installment of our Grand Rounds Webinar Series: "Research 101: What data can I report from my TMS practice\, and how can I report it?"\nSpeaker: Andrew F. Leuchter\, MD\nrTMS is a rapidly growing area of clinical practice. Many practitioners have created innovative approaches to treatment\, observed novel findings that could help improve outcomes\, or discovered new potential indications for rTMS treatment. This presentation will review the types of data that can be reported in the scientific and clinical literature\, how to approach creating a report\, and how to find the right "home" for publication. \nKey learning objectives include:\n\nPresent goals of naturalistic research in TMS practice.\nDiscuss different types of research report formats.\nConsider what constitutes a meaningful contribution to the literature.\n\nTake advantage of our live Q&A session at the conclusion of the webinar. \nOne CME credit is available.  CE Language\n \n*Registered attendees will receive access to the on-demand video recording by Friday\, May 9\, 2025. You will receive an email notification with instructions on accessing the video. You may register for the on-demand webinar any time after the live webinar. \nWhen:\nUSA - May 6\, 2025 at 8:00pm ET | 5:00pm PT\nUK- May 7\, 2025 at 1:00am BST\nAustralia- May 7\, 2025 at 10:00am AEST \nCost: \nMember: $25\nTrainee Member: FREE\nNon-Member: $50 \nAll Grand Rounds are recorded and available On-Demand. Recordings are available by the Friday after the live event. \n> >Register Now <<\nAbout the Speaker: Andrew F. Leuchter\, MD\nAndrew F. Leuchter\, MD\, is a Distinguished Professor of Psychiatry and Director of the Neuromodulation Division at UCLA. An expert on the treatment of mood disorders\, Dr. Leuchter directs the Transcranial Magnetic Stimulation (TMS) Clinical and Research Service. This is one of\nthe largest academic TMS program in the country and treats patients with depression\, OCD\, pain\, tinnitus\, and other neuropsychiatric illness. His research aims to develop novel treatment strategies and predict which treatments are most likely to benefit individual patients. \nDr. Leuchter has authored over 200 scientific articles on topics including neuromodulation for the treatment of depression\, EEG biomarkers to guide treatment of neuropsychiatric illness\, and theories of antidepressant action. He teaches internationally on TMS and other neuromodulation methods\, and received the 2019 Outstanding Research Mentor Award from the Semel Institute. \nAndrew F. Leuchter\, MD\, is a Distinguished Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior\, and Director of the Neuromodulation Division at the Semel Institute. An expert on the treatment of mood disorders\, Dr. Leuchter directs the Transcranial Magnetic Stimulation (TMS) Clinical and Research Service. This is one of the largest academic TMS programs\, performing clinical treatment and translational research across campuses throughout Los Angeles. The dual mission of the Division is to provide care for patients with depression\, chronic pain\, OCD\, tinnitus\, and other difficult-to-treat neuropsychiatric illness\, as well as enhancing treatment effectiveness\, as well as clinical trials to improve treatment of depression\, Post-Traumatic Stress Disorder (PTSD)\, and Attention-Deficit/Hyperactivity Disorder (ADHD). Dr. Leuchter’s research aims to develop novel treatment strategies and uses brain-imaging techniques\, such as quantitative electroencephalography (qEEG) and magnetic resonance imaging (MRI) to examine brain function and predict which treatments are most likely to benefit individual patients. \n> >Register Now <<
URL:https://clinicaltmssociety.org/event/grand-round-webinar-research-101-what-data-can-i-report-from-my-tms-practice-and-how-can-i-report-it/
LOCATION:Zoom
CATEGORIES:Grand Rounds Webinar
END:VEVENT
END:VCALENDAR